In vitro susceptibility of Campylobacter fetus subsp. jejuni to N-formimidoyl thienamycin, rosaramicin, cefoperazone, and other antimicrobial agents | Zendy

Vincent I. Ahonkhai | Zendy; Charles E. Cherubin | Zendy; Marcelino F. Sierra | Zendy; V. Bokkenheuser | Zendy; M A Shulman | Zendy; Anne C. Mosenthal | Zendy

Open Access

In vitro susceptibility of Campylobacter fetus subsp. jejuni to N-formimidoyl thienamycin, rosaramicin, cefoperazone, and other antimicrobial agents

Author(s) -

Vincent I. Ahonkhai,

Charles E. Cherubin,

Marcelino F. Sierra,

V. Bokkenheuser,

M A Shulman,

Anne C. Mosenthal

Publication year - 1981

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.20.6.850

Subject(s) - cefoperazone , thienamycin , antimicrobial , microbiology and biotechnology , campylobacter fetus , cefotaxime , broth microdilution , moxalactam , campylobacter jejuni , chemistry , antibiotics , imipenem , biology , minimum inhibitory concentration , bacteria , antibiotic resistance , genetics

The activities of 11 antimicrobial agents against 36 strains of Campylobacter fetus subsp. jejuni were studied by a broth microdilution method. All strains were susceptible to 7 of the 11 antimicrobial agents. Of the newer agents tested N-formimidoyl thienamycin (MK0787) and rosaramicin had very good activity, whereas cefotaxime, moxalactam, and cefoperazone had poorer activity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research